Chronic inflammation is an important contributor to tumorigenesis in many tissues. However,
the underlying mechanisms of inflammatory signaling in the tumor microenvironment are not …

Lychnis coronaria, a perennial (herbaceous) belonging to Caryophyllaceae has been
traditionally used for treating different complications. However, the free radical scavenging …

Abstract β‐arrestin 2 (ARRB2) is functionally implicated in cancer progression via various
signaling pathways. However, its role in lung cancer remains unclear. To obtain clinical …

Background: Lung adenocarcinoma (LUAD) is the leading histological subtype of lung
cancer worldwide, causing high mortality each year. The tumor immune cell infiltration (ICI) …

Tissue damage and cell death occurring during photothermal therapy (PTT) for tumors can
induce an inflammatory response that is detrimental to tumor therapy. Herein, ultrathin Mo …

Immune checkpoint inhibitor-based immunotherapy has revolutionized the treatment
approach of non-small cell lung cancer (NSCLC). Monoclonal antibodies against …

Lung cancer is the leading cause of cancer-related deaths worldwide. This study aimed to
compare the bronchial microbiota of patients with lung cancer and patients with benign …

Lung cancer is a serious health and life issue, with the fastest-growing incidence and fatality
rates worldwide. It is now clear that inflammation is a key factor involved in all aspects of …

Background Lung cancer is the leading cause of cancer morbidity and mortality worldwide.
Apart from tobacco smoke and dietary factors, microbial infections have been reported as …

Background Previous studies conducted among European and Asian decedents reported
inverse associations of serum total bilirubin and albumin with lung cancer risk. Yet, no study …